[Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma].

Xu, S S; Wang, L M; Zhao, L H; He, Z L; Gong, L P; Lu, D H; Teng, L H

Xu, S S; Wang, L M; Zhao, L H; He, Z L; Gong, L P; Lu, D H; Teng, L H.

Afiliación

Xu SS; Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; Department of Pathology, Capital Medical University, Beijing 100069, China.
Wang LM; Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Zhao LH; Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
He ZL; Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Gong LP; Department of Pathology, Capital Medical University, Beijing 100069, China.
Lu DH; Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Teng LH; Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

Zhonghua Bing Li Xue Za Zhi ; 48(9): 682-687, 2019 Sep 08.

Article en Zh | MEDLINE | ID: mdl-31495087

Asunto(s)

Craneofaringioma; Neoplasias Hipofisarias; Proteínas Proto-Oncogénicas B-raf/genética; beta Catenina/genética; Craneofaringioma/genética; Humanos; Mutación; Recurrencia Local de Neoplasia; Neoplasias Hipofisarias/genética; Proto-Oncogenes Mas; Estudios Retrospectivos

Palabras clave

Craniopharyngioma; Prognosis; Proto-oncogene proteins B-raf; beta Catenin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Craneofaringioma / Proteínas Proto-Oncogénicas B-raf / Beta Catenina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google